$10.350
+0.309 (+2.99%)Al cierre
Comparativa sectorial de INKT
In the context of the broader market, INKT competes directly with industry leaders such as HYFT and ONCY. With a market capitalization of $52.79M, it holds a significant position in the sector. When comparing efficiency, INKT's gross margin of N/A stands against HYFT's 58.58% and ONCY's N/A. Such benchmarking helps identify whether Mink Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Mink Therapeutics Inc
The company reported a net loss of $3.1 million in Q2 2026, which is an improvement from previous quarters but still indicates ongoing financial challenges. The current ratio is 1.23, suggesting that the company can cover its short-term liabilities, but the overall financial health remains weak with total equity at -$14.03 million as of Q2 2026.
Financials
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.